4536/N fundamentals
An in-depth look to SANTEN PHARMACEUTICAL CO operating, investing, and financing activities
4536/N free cash flow for Q4 23 is 1.08 B MXN. For 2023, 4536/N free cash flow was 6.93 B MXN and operating cash flow was 7.95 B MXN.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM